T1	Participants 45 84	radiotherapeutic outcome in RTOG #77-06
T2	Participants 220 359	patients treated for localized prostatic carcinoma in a Phase III radiotherapy (RT) protocol, Radiation Therapy Oncology Group (RTOG) 77-06
T3	Participants 729 779	449 eligible males were entered into RTOG protocol
